ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 156 filers reported holding ANIKA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $583,529 | -71.9% | 31,322 | -60.7% | 0.00% | -100.0% |
| Q2 2023 | $2,073,022 | -7.8% | 79,793 | +1.9% | 0.00% | 0.0% |
| Q1 2023 | $2,248,202 | -19.5% | 78,280 | -17.0% | 0.00% | 0.0% |
| Q4 2022 | $2,791,162 | +38.9% | 94,296 | +11.7% | 0.00% | 0.0% |
| Q3 2022 | $2,009,000 | +4.7% | 84,430 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,919,000 | -10.7% | 85,973 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $2,148,000 | -30.4% | 85,551 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $3,086,000 | -19.3% | 86,136 | -4.1% | 0.00% | 0.0% |
| Q3 2021 | $3,822,000 | -7.5% | 89,797 | -5.9% | 0.00% | 0.0% |
| Q2 2021 | $4,133,000 | +2.8% | 95,464 | -3.1% | 0.00% | 0.0% |
| Q1 2021 | $4,020,000 | -5.0% | 98,562 | +5.4% | 0.00% | 0.0% |
| Q4 2020 | $4,233,000 | +14.8% | 93,507 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $3,687,000 | -20.2% | 104,164 | -14.9% | 0.00% | -50.0% |
| Q2 2020 | $4,621,000 | +27.8% | 122,458 | -2.1% | 0.00% | 0.0% |
| Q1 2020 | $3,616,000 | -47.0% | 125,102 | -5.0% | 0.00% | 0.0% |
| Q4 2019 | $6,825,000 | -6.2% | 131,637 | -0.7% | 0.00% | 0.0% |
| Q3 2019 | $7,274,000 | +73.7% | 132,530 | +28.5% | 0.00% | +100.0% |
| Q2 2019 | $4,188,000 | -0.3% | 103,099 | -25.8% | 0.00% | 0.0% |
| Q1 2019 | $4,200,000 | -20.4% | 138,876 | -11.6% | 0.00% | -50.0% |
| Q4 2018 | $5,279,000 | -41.3% | 157,071 | -26.3% | 0.00% | -33.3% |
| Q3 2018 | $8,994,000 | +120.2% | 213,220 | +67.1% | 0.00% | +200.0% |
| Q2 2018 | $4,084,000 | +9.6% | 127,632 | +70.3% | 0.00% | 0.0% |
| Q1 2018 | $3,727,000 | +29.8% | 74,954 | +40.7% | 0.00% | 0.0% |
| Q4 2017 | $2,872,000 | +3.8% | 53,266 | +11.6% | 0.00% | 0.0% |
| Q3 2017 | $2,768,000 | -71.0% | 47,717 | -75.3% | 0.00% | -66.7% |
| Q2 2017 | $9,547,000 | +379.7% | 193,494 | +322.5% | 0.00% | +200.0% |
| Q1 2017 | $1,990,000 | -4.4% | 45,801 | +7.7% | 0.00% | 0.0% |
| Q4 2016 | $2,082,000 | -7.7% | 42,535 | -9.7% | 0.00% | 0.0% |
| Q3 2016 | $2,255,000 | -21.6% | 47,114 | -12.2% | 0.00% | 0.0% |
| Q2 2016 | $2,877,000 | +52.8% | 53,636 | +27.4% | 0.00% | 0.0% |
| Q1 2016 | $1,883,000 | -4.2% | 42,097 | -18.3% | 0.00% | 0.0% |
| Q4 2015 | $1,965,000 | +26.7% | 51,506 | +5.7% | 0.00% | 0.0% |
| Q3 2015 | $1,551,000 | +13.4% | 48,722 | +17.7% | 0.00% | 0.0% |
| Q2 2015 | $1,368,000 | -15.2% | 41,403 | +5.6% | 0.00% | 0.0% |
| Q1 2015 | $1,613,000 | +13.3% | 39,189 | +12.1% | 0.00% | 0.0% |
| Q4 2014 | $1,424,000 | +0.5% | 34,965 | -9.6% | 0.00% | 0.0% |
| Q3 2014 | $1,417,000 | -75.4% | 38,670 | -68.9% | 0.00% | -50.0% |
| Q2 2014 | $5,758,000 | +2.1% | 124,268 | -9.4% | 0.00% | 0.0% |
| Q1 2014 | $5,638,000 | +46.3% | 137,182 | +35.9% | 0.00% | 0.0% |
| Q4 2013 | $3,853,000 | – | 100,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |